Medplus Health Services Share Price Target For Tomorrow, Next Week & Next Month
MedPlus Health Services Limited | |||
 | Price: ₹813.80 (+1.21%) | ||
| 52 Week Low: ₹616.00 52 Week High: ₹1,045.30 | |||
| Market Capital: 8,412.54 Crore (Midcap) | |||
| Healthcare -> Pharmaceutical Retailers | |||
Medplus Health Services Stock Comparison: Medplus Health Services vs Sastasundar Ventures | Medplus Health Services vs Wockhardt | Medplus Health Services vs FDC | Medplus Health Services vs Strides Pharma Science | Medplus Health Services vs Procter & Gamble Health | Medplus Health Services vs Vijaya Diagnostic Centre | |||
Show Table of Contents
Medplus Health Services Recent Performance
Over the past 438 trading days, the value of Medplus Health Services's stock has gained ₹10.60 (+1.32%). On 07 Nov 2023, one share was worth ₹803.20 and by 14 Aug 2025, the value jumped to ₹813.80. During this period it created a highest high of ₹1045.30 and lowest low of ₹598.60.
Medplus Health Services Share Price Target - Tomorrow
| Level | Value | Analysis |
|---|---|---|
| Tomorrow Target 3 | 886.95 (+8.98%) | Price Action: 01 Jul 2025 Low |
| Tomorrow Target 2 | 878 (+7.88%) | Price Action: 15 Jul 2025 Low |
| Tomorrow Target 1 | 869 (+6.78%) | Price Action: 09 Jul 2025 High |
| Current Price | 813.80 | Medplus Health Services's share price as of 14 Aug 2025 |
| Stop Loss 1 | 762 (-6.37%) | Price Action: 09 Apr 2025 High |
| Stop Loss 2 | 753.95 (-7.36%) | Price Action: 27 Mar 2025 High |
| Stop Loss 3 | 745.5 (-8.4%) | Price Action: 01 Apr 2025 Low |
Summary
14 Aug 2025: Medplus Health Services finished the day at ₹813.80, gaining ₹9.75 (+1.21%) in 1 day.
Our analysis for tomorrow predicts a potential movement of -8.39% to 8.99% with:
- Target prices: ₹869 to ₹886.95
- Support levels: ₹762 to ₹745.5
- Recent high: ₹829.60
- Recent low: ₹805.35
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Medplus Health Services Share Price Target - Next Week
| Level | Value | Analysis |
|---|---|---|
| Next Week Target 3 | 843.8 (+3.68%) | Price Action: Jul 2025 Low |
| Next Week Target 2 | 835.2 (+2.62%) | Price Action: 12 Aug 2025 High |
| Next Week Target 1 | 825.4 (+1.42%) | Price Action: Oct 2023 High |
| Current Price | 813.80 | Medplus Health Services's share price as of 14 Aug 2025 |
| Stop Loss 1 | 810.1 (-0.46%) | Price Action: 08 Aug 2025 Low |
| Stop Loss 2 | 801.27 (-1.54%) | Fibonacci Retracement Level 98.60% |
| Stop Loss 3 | 792.35 (-2.64%) | Price Action: 21 Apr 2025 Low |
Weekly Target Summary
For next week, our analysis suggests a potential movement range of -2.64% to 3.69% with:
- Upper targets: ₹825.4 to ₹843.8
- Support levels: ₹810.1 to ₹792.35
Medplus Health Services Share Price Target - Next Month
| Level | Value | Analysis |
|---|---|---|
| Next Month Target 3 | 902.25 (+10.86%) | Price Action: 02 Jul 2025 High |
| Next Month Target 2 | 892.75 (+9.69%) | Price Action: 24 Jul 2025 High |
| Next Month Target 1 | 883.8 (+8.6%) | Price Action: 02 Jul 2025 Low |
| Current Price | 813.80 | Medplus Health Services's share price as of 14 Aug 2025 |
| Stop Loss 1 | 793.65 (-2.48%) | Price Action: 22 Apr 2025 Low |
| Stop Loss 2 | 785.5 (-3.48%) | Price Action: 30 Apr 2025 Low |
| Stop Loss 3 | 777.25 (-4.5%) | Price Action: Dec 2024 Low |
Monthly Target Summary
Looking ahead to next month, technical analysis indicates:
- Potential price movement: -4.49% to 10.87% with:
- Target range: ₹883.8 to ₹902.25
- Support levels: ₹793.65 to ₹777.25
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
